PC
GCVRZ

Permanens Capital’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Permanens Capital’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-112,982
Closed -$48K – 25
2018
Q1 		$48K Buy
+112,982
New +$45.5K 0.02% 23
2016
Q4 		– Sell
-112,982
Closed -$31K – 15
2016
Q3 		$31K Hold
112,982
– – 0.02% 12
2016
Q2 		$27K Buy
+112,982
New +$19.4K 0.02% 11
2016
Q1 		– Sell
-112,982
Closed -$13K – 15
2015
Q4 		$13K Buy
+112,982
New +$16K 0.01% 11

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Permanens Capital's GCVRZ Position: Q2 2018 in Review

Permanens Capital sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2018, closing a stake of 112,982 shares — an estimated $48K sold.

Permanens Capital first reported a position in GCVRZ in Q4 2015 and held it in 4 quarters. The position peaked at $48K in Q1 2018. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2018.

  • Permanens Capital reported no remaining Sanofi Contingent Value Rights position as of Q2 2018 after selling out during the quarter.
  • Permanens Capital sold 112,982 Sanofi Contingent Value Rights shares in Q2 2018, an estimated $48K.
  • Permanens Capital first reported a position in Sanofi Contingent Value Rights in Q4 2015 and held it in 4 quarters.
  • Permanens Capital's Sanofi Contingent Value Rights position peaked at $48K in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2018.

Based on Permanens Capital's 13F filing for Q2 2018, filed 14 Aug 2018.